Viewing Study NCT01618305


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-31 @ 3:38 AM
Study NCT ID: NCT01618305
Status: COMPLETED
Last Update Posted: 2020-01-30
First Post: 2012-06-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Sponsor: Westat
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-09-05
Start Date Type: ACTUAL
Primary Completion Date: 2018-12-11
Primary Completion Date Type: ACTUAL
Completion Date: 2018-12-11
Completion Date Type: ACTUAL
First Submit Date: 2012-06-06
First Submit QC Date: None
Study First Post Date: 2012-06-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-12-10
Results First Submit QC Date: None
Results First Post Date: 2019-12-26
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-01-14
Last Update Post Date: 2020-01-30
Last Update Post Date Type: ACTUAL